264 related articles for article (PubMed ID: 18490300)
41. Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.
Beer M; Weidemann F; Breunig F; Knoll A; Koeppe S; Machann W; Hahn D; Wanner C; Strotmann J; Sandstede J
Am J Cardiol; 2006 May; 97(10):1515-8. PubMed ID: 16679096
[TBL] [Abstract][Full Text] [Related]
42. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization.
Pieroni M; Chimenti C; De Cobelli F; Morgante E; Del Maschio A; Gaudio C; Russo MA; Frustaci A
J Am Coll Cardiol; 2006 Apr; 47(8):1663-71. PubMed ID: 16631007
[TBL] [Abstract][Full Text] [Related]
43. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
Spinelli L; Pisani A; Sabbatini M; Petretta M; Andreucci MV; Procaccini D; Lo Surdo N; Federico S; Cianciaruso B
Clin Genet; 2004 Aug; 66(2):158-65. PubMed ID: 15253767
[TBL] [Abstract][Full Text] [Related]
44. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.
Mahmud HM
J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811
[TBL] [Abstract][Full Text] [Related]
45. First-degree atrioventricular block and restrictive physiology as cardiac manifestations of Fabry's disease.
Blum A; Ashkenazi H; Haromankov I; Khazim K; Sheiman J
South Med J; 2003 Feb; 96(2):212-3. PubMed ID: 12630653
[TBL] [Abstract][Full Text] [Related]
46. Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry's disease.
Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Murao K; Kohno M; Itoh S
Tohoku J Exp Med; 2009 Mar; 217(3):169-74. PubMed ID: 19282651
[TBL] [Abstract][Full Text] [Related]
47. Anderson-Fabry's disease with marfanoid features.
Surjushe A; Jindal S; Sao P; Medhekar S; Saple DG
Indian J Dermatol Venereol Leprol; 2008; 74(4):389-91. PubMed ID: 18797069
[No Abstract] [Full Text] [Related]
48. Alpha-galactosidase A deficiency (Fabry's disease) in a black Zimbabwean.
Borok MZ; Gabriel R
S Afr Med J; 1993 May; 83(5):350-1. PubMed ID: 8211434
[TBL] [Abstract][Full Text] [Related]
49. Atypical Fabry's disease. An oligosymptomatic variant.
Ko YH; Kim HJ; Roh YS; Park CK; Kwon CK; Park MH
Arch Pathol Lab Med; 1996 Jan; 120(1):86-9. PubMed ID: 8554452
[TBL] [Abstract][Full Text] [Related]
50. [Cardiac involvement in Fabry's disease].
Weidemann F; Breunig F
Med Klin (Munich); 2008 Mar; 103(3):161-5. PubMed ID: 18344066
[TBL] [Abstract][Full Text] [Related]
51. [Intravenous enzyme substitution therapy in children with Fabry's disease].
Tøndel C; Laegreid LM; Hirth A; Houge G; Månsson JE; Søvik O
Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3388-90. PubMed ID: 14713976
[TBL] [Abstract][Full Text] [Related]
52. A case of Fabry's disease.
Miura M; Tomino Y; Inoue W; Endoh M; Suga T; Kaneshige H; Nomoto Y; Sakai H; Matsuo I; Nagura H; Ikeda N
Tokai J Exp Clin Med; 1983 Jan; 8(1):23-9. PubMed ID: 6310828
[TBL] [Abstract][Full Text] [Related]
53. Fabry disease with early-onset ventricular dilation: A case report.
Tang J; Wu C; Cao J; Wang L
Medicine (Baltimore); 2020 Sep; 99(39):e22326. PubMed ID: 32991443
[TBL] [Abstract][Full Text] [Related]
54. [Echocardiographic findings in a case of Fabry's disease with aortic regurgitation and complete AV block, and in his family members].
Iwase M; Yamauchi K; Maeda M; Aoki T; Yokota M; Hayashi H; Sotobata I
J Cardiol; 1988 Jun; 18(2):589-98. PubMed ID: 3150446
[TBL] [Abstract][Full Text] [Related]
55. Cardiac manifestations of Fabry's disease: a story of mother and son.
Moses H; Yarnoz MJ; Guglin M
Congest Heart Fail; 2009; 15(2):93-5. PubMed ID: 19379456
[No Abstract] [Full Text] [Related]
56. [Cryptogenic stroke in a young patient with heart disease and kidney failure].
Oyanguren B; Segoviano R; Alegria E; Besada E; Gonzalez-Salaices M; Eimil-Ortiz M; Lopez de Silanes C
Rev Neurol; 2017 May; 64(10):454-458. PubMed ID: 28497441
[TBL] [Abstract][Full Text] [Related]
57. Fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy.
Teragaki M; Tanaka A; Akioka K; Lan HT; Nishi Y; Yamano T; Yoshikawa J
Jpn Heart J; 2004 Jul; 45(4):685-9. PubMed ID: 15353880
[TBL] [Abstract][Full Text] [Related]
58. Avascular necrosis of bilateral femoral heads in a patient with Fabry's disease.
O'Neill F; Rice J
Hip Int; 2012; 22(1):119-21. PubMed ID: 22383317
[TBL] [Abstract][Full Text] [Related]
59. Outcome of septal myectomy in patients with Fabry's disease.
Kunkala MR; Aubry MC; Ommen SR; Gersh BJ; Schaff HV
Ann Thorac Surg; 2013 Jan; 95(1):335-7. PubMed ID: 23272855
[TBL] [Abstract][Full Text] [Related]
60. [Fabry's disease; towards a treatment].
Linthorst GE; Hollak CE; Bosman DK; Heymans HS; Aerts JM
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2391-5. PubMed ID: 11145093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
